QED International Associates Announces Changes to the HealthShares(TM) Dermatology and Wound Care Index
22 February 2008 - 10:54AM
PR Newswire (US)
NEW YORK, Feb. 21 /PRNewswire/ -- QED International Associates,
Inc., administrator for the HealthShares(TM) Indexes, a series of
20 underlying indexes for the HealthShares(TM) Exchange-Traded
Funds, today announced that effective at the opening of trading on
Tuesday February 26, 2008, KV Pharmaceutical Co. (NYSE:KV.A) will
replace Bradley Pharmaceuticals, Inc. (NYSE:BDY) in the
HealthShares(TM) Dermatology and Wound Care Index. Bradley is being
acquired by Nycomed US Inc., a subsidiary of Nycomed S.C.A., SICAR,
a Zurich-based private pharmaceutical company. Companies included
in the Dermatology and Wound Care Index are engaged in the
research, clinical development and/or commercialization of
therapeutic agents for the treatment of a wide variety of skin
disorders by topical or systemic means. About QED International
Associates QED International Associates, based in New York, is a
leading financial industry consulting firm specializing in
quantitative modeling and the design, development and maintenance
of indexes and Exchange Traded Funds. For more information, visit
the company's website at http://www.qedinternational.com/
DATASOURCE: QED International Associates, Inc. CONTACT: Ed Matluck,
CEO, or Michael Carty, Senior Advisor, both for QED International
Associates: +1-212-953-4058, Web site:
http://www.qedinternational.com/
Copyright
Bradley (NYSE:BDY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bradley (NYSE:BDY)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bradley Pharmaceuticals (New York Stock Exchange): 0 recent articles
More Bradley Pharmaceuticals News Articles